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Clinical Effectiveness of Ultrasound-guided Costotransverse 
Joint Injection in Thoracic Back Pain Patients
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Yonsei University College of Medicine, Seoul, Korea
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Because of its anatomical location and function, the costotransverse (CTRV) joint can be a source of thoracic 
back pain. In this retrospective observational study, we evaluated the clinical effectiveness of the CTRV joint 
injection in thoracic back pain patients with suspected CTRV joint problems. We enrolled 20 thoracic back 
pain patients with localized tenderness that was provoked by the application of pressure on the affected CTRV 
joints. We injected it with 0.5 ml of a ropivacaine and triamcinolone mixture at each level. The mean 
pre-injection pain score decreased by 37.9% (7.2 ± 1.5 to 4.5 ± 1.7, P ＜ 0.001) two weeks after CTRV joint 
injection. In addition, 70% of patients reported an excellent or good level of satisfaction. We demonstrated 
that an ultrasound-guided injection of the CTRV joint reduced patients’ pain scores and led to a high level 
of satisfaction at short-term follow-ups in patients with suspected CTRV joint problems. (Korean J Pain 2016; 
29: 197-201)
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INTRODUCTION
Many potential pain generators exist in the thoracic 
spine, and variable clinical symptoms and the close prox-
imity of related anatomical structures lead to poor local-
ization of the exact pain source. Therefore, the diagnosis 
and treatment of thoracic back pain have been historically 
considered difficult for the pain physician [1]. Thoracic fac-
et joints and intervertebral disks are considered to be the 
most typical pain sources in the thoracic spine; therefore, 
clinical practice has focused on the assessment and treat-
ment of these structures [2-4]. The costovertebral and 
costotransverse (CTRV) joints are the articulations that 
connect the ribs with the bodies of the thoracic vertebrae 
and transverse processes (Fig. 1) [5]. The costovertebral 
and CTRV joints also significantly contribute to the stability 
and movement of the thoracic spine, which is not limited 
to motion of the ribs [6,7]. Although the CTRV joints are 
relatively less studied compared to the thoracic facet joints 
and intervertebral disks, it has been well established that 
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Fig. 1. (A) Rib head contact with the vertebral body via two joints. Costotransverse and costovertebral joints. (B) Ultrasound
image of CTRV joint. With an in-plane approach, the needle was advanced medially toward the CTRV joint. As the needle
passed under the transverse process of the target CTRV joint, it was advanced until the tip penetrated the capsule. TP: 
transverse process, R: rib, L: lung, N: needle.
the CTRV joints may produce clinically significant thoracic 
back pain [1,8-11]. Therefore, we hypothesized that the 
CTRV joints might be a source of pain and that this treat-
ment could lead to clinical improvements. The aim of this 
study is to evaluate the clinical effectiveness of the CTRV 
joint injection in thoracic back pain patients with suspected 
CTRV joint problems.
MATERIALS AND METHODS
This study is a retrospective observational audit of pa-
tients who received a CTRV joint injection for pain treat-
ment. We reviewed clinical records and interviewed patients 
individually at a follow-up visit or via telephone. The study 
protocol was approved by the institutional review board, 
and written informed consent was obtained from all pa-
tients on an outpatient basis. The study population was 
defined as thoracic back pain patients with localized para-
spinal tenderness 2-3 cm lateral to the midline where the 
transverse process meets the rib, at anticipated points 
that correspond to the CTRV joint on physical examination. 
The patients were placed in the prone position during 
prescanning for identification of the 12th rib to investigate 
the thoracic level of the target CTRV joint using an ultra-
sound machine with a 7.5-MHz linear probe (SonoSite 
S-Nerve Ultrasound System, Sonosite, Bothell, WA, USA). 
All ultrasound-guided CTRV joint injections were per-
formed by one pain physician (K.B.Y.) as previously de-
scribed by Deimel et al. [10]. For image optimization, we 
identified the transverse process, CTRV joint, rib, and lung 
in the same plane (Fig. 1). With an in-plane approach, the 
needle was advanced medially toward the CTRV joint. As 
the needle passed under the transverse process of the tar-
get CTRV joint, it was advanced until the tip penetrated 
the capsule (Fig. 1). Thereafter, 0.5 ml of triamcinolone 
acetonide 2.5 mg and 0.75% ropivacaine mixture were in-
jected at each CTRV joint. 
Clinical and demographic data were collected for anal-
ysis, including age, gender, coexisting pain sites, duration 
of pain, previous pain intervention history, characteristics 
of thoracic back pain, and CTRV joint injection sites. 
Before and two weeks after CTRV joint injection, patients 
were asked to rate their pain score using a 10-point nu-
meric rating scale (NRS; 0 = no pain, 10 = worst possible 
pain). We also assessed the degree of patient satisfaction 
as excellent, good, fair, or bad two weeks after injection. 
Continuous data are reported as mean and standard 
deviation (SD) unless otherwise indicated. The normality of 
data distribution was assessed using the Shapiro–Wilk test. 
Categorical data are reported as both the number of pa-
tients and the percentage. A paired t-test was used to 
compare mean pain scores before and two weeks after 
CTRV joint injection. Statistical analyses were performed 
with SPSS statistical software, version 18.0 (SPSS Inc., 
Chicago, IL, USA). A P value ＜ 0.05 was considered stat-
istically significant.
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Table 1. Patient Characteristics and Pain Profile
Gender (M/F) 8/12
Age, years 51.4 ± 18.9 (20−88)
Pain duration, months 21.3 ± 28.2 (1 month−10 years)
Coexisting pain sites, n (%)
  Only thoracic back 4 (20)
  Headache 3 (15)
  Posterior neck 5 (25)
  Shoulder 6 (30)
  Arm 3 (15)
  Flank 3 (15)
  Lower lumbar or legs 5 (25)
Previous pain intervention, n (%)
  Thoracic medial branch block 20 (100)
  Cervical medial branch block 4 (20)
  Thoracic epidural block 5 (25)
  Trigger point injection 9 (45)
  Intercostal nerve block 1 (5)
  Other procedures 2 (10)
Values are means ± SD (range) or number of patients (%). 
Table 2. Injection Sites for Costotransverse Joint Injections
Injection sites, n Left side Right side
T3 3 1
T4 2 1
T5 2 3
T6 4 1
T7 1 2
T8 4 1
T9 0 1
T10 2 4
Total 18 14
Values are the number of patients who received an injection at 
each site. 
Table 3. Pain Scores before and Two Weeks after Costotransverse
Joints Injection and the Degree of Patient Satisfaction Two Weeks
after Injection
Pre-injection pain score, 0 to 10 NRS 7.2 ± 1.5 (5−10) 
Post-injection pain score, 0 to 10 NRS 4.5 ± 1.7 (2−8)*
Patient satisfaction, n (%)
  Excellent 4 (20)
  Good 10 (50)
  Fair 6 (30)
  Bad 0 (0)
Values are means ± SD (range) or number of patients (%). NRS,
numeric rating scale. *P ＜ 0.001, The mean pre-injection pain 
score decreased by 37.9% two weeks after costotransverse joint 
injection.
RESULTS
Twenty consecutive patients who were treated with 
CTRV joint injections were enrolled in this study. 
Patient characteristics and pain-related data are 
shown in Table 1. Patients enrolled in this study previously 
experienced a variety of interventional procedures for 
thoracic back pain treatment. In particular, all patients had 
previously experienced thoracic medial branch blocks, but 
they reported no lasting improvement after any of these 
interventions.
Injection sites for the CTRV joint injections are listed 
in Table 2. Twenty symptomatic thoracic back pain patients 
received a combined total of 32 CTRV injections at the 
T3-T10 spine levels. 
Table 3 shows the change in pain scores before and 
after the CTRV joint injection treatment, and the degree 
of patient satisfaction two weeks after the treatment. The 
mean pre-procedure pain score decreased by 37.9% (7.2 
± 1.5 to 4.5 ± 1.7, P ＜ 0.001) two weeks after CTRV 
joint injection. Although most patients reported reduced 
pain two weeks after injection, two patients reported the 
same pain score. In addition, 70% of patients (14/20) re-
ported excellent or good satisfaction levels during the two 
weeks after the injection. 
DISCUSSION
This study reports the clinical outcomes of CTRV joint 
injection for treating CTRV joint–generated pain. We dem-
onstrated that an ultrasound-guided CTRV joint injection 
with local anesthetic and steroid led to reduced pain scores 
and a high level of satisfaction at short-term follow-ups 
of thoracic back pain patients with suspected CTRV joint 
problems. 
The provoked pain patterns of thoracic facet joints 
overlap considerably in the thoracic area, and no referral 
zone can be attributed solely to one joint [12,13]. In con-
trast to the thoracic facet joint, the CTRV joint pain pat-
tern is very localized and presents with mainly unilateral 
symptoms which are limited to the affected CTRV joint 
[1,9]. This pain pattern is also distinguished from referred 
pain caused by an active trigger point on the rhomboid or 
trapezius muscles [1]. Interestingly, all patients had pre-
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viously received thoracic medial branch blocks. In humans, 
the medial branches of the thoracic dorsal rami innervate 
the thoracic facet joints, whereas innervation of the CTRV 
joints comes from the lateral branch of the thoracic dorsal 
rami [11]. Therefore, conventional thoracic medial branch 
interventions may not fully relieve pain originating from 
the CTRV joints. 
Costovertebral joints, which receive sympathetic in-
nervation, have also been known to cause thoracic back 
pain [1]. However, this joint pain pattern sometimes radi-
ates to the anterior chest area, similar to visceral-origin 
chest pain, which is called atypical chest pain and pseu-
do-angina [1,14]. Some studies have demonstrated that in-
tercostal nerve blocks effectively reduced this costoverte-
bral joint-generated pain [14]. Although no patients re-
ported radiating pain to the anterior chest wall in this 
study, we cannot fully exclude costovertebral joint prob-
lems in some patients because the costovertebral and 
CTRV joints have a very close biomechanical relationship 
that is associated with rib movements [6,7]. It is therefore 
difficult to differentiate which of the costovertebral or 
costotransverse joints is problematic with any kind of spe-
cificity on manual testing [1]. Moreover, ultrasound guid-
ed-costovertebral joint injection is technically very difficult 
due to its location. 
The CTRV joint is the joint formed between the facet 
of the tubercle of the rib and the adjacent transverse 
process of a thoracic vertebra [5]. The CTRV joint is a 
plane-type synovial joint which allows both gliding and ro-
tation of the connected rib [5-7]. The pathophysiology of 
CTRV joint problems has not been completely elucidated, 
but in a recent histological study, immunoreactivity was 
confirmed for specific neuropeptides within the CTRV joint 
tissue samples, which suggests that the CTRV joint is gen-
erating pain [11]. On the other hand, a partial resection 
model of the CTRV joint in canines demonstrated that the 
CTRV joint participates as a stabilizer of the thoracic spine 
along with the thoracic intervertebral disk and costoverte-
bral joint [6]. This finding suggests that CTRV joint dys-
function may affect or be affected by thoracic spine 
destabilization. 
This study has several limitations. The small number 
of patients and lack of a control group impaired this study, 
and we did not conduct long-term follow-up. We cannot 
suggest specific diagnostic methods that identify CTRV 
joint problems among various overlapping anatomical 
structures, other than typical tenderness and related clini-
cal manifestations. Therefore, a more controlled study is 
needed to determine the exact source of pain, such as a 
staged diagnostic block in the surrounding structures of 
the thoracic spine. 
In conclusion, we demonstrated clinical improvements 
in thoracic back pain patients after a CTRV joint injection. 
Ultrasound-guided CTRV joint injections reduced patients’ 
pain scores and led to a high level of satisfaction at 
short-term follow-up in patients with suspected CTRV 
joint-generated pain. The results of this study suggest 
that CTRV injection should be considered as a therapeutic 
option to solve complex problems of thoracic back pain in 
selected patients. 
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